Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist

Neuroscience

Volumn 121, Issue 4, 2003, Pages 847-853

  Barrientos, R M ^a   Sprunger, D B ^a   Campeau, S ^a   Higgins, E A ^a   Watkins, L R ^a   Rudy, J W ^a   Maier, S F ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Brain derived neurotrophic factor; Hippocampus; Interleukin 1 receptor antagonist; Interleukin 1 ; Memory consolidation; Pro inflammatory cytokines

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONDITIONING; CONTROLLED STUDY; DENTATE GYRUS; DOCUMENTATION; DOWN REGULATION; DRUG EFFECT; FEAR; HIPPOCAMPUS; MALE; MEMORY DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SOCIAL ISOLATION;

EID: 0142247472     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00564-5     Document Type: Article

References (43)

1. Adams D.H., Hunsberger J.G., Sathyanesan S.N., Chen J.S., Duman R.S. Identification of regulated genes in the learned helplessness model of depression. 2002;Proceedings of the Society of Neuroscience, Orlando, FL.
2. Alvarez P., Squire L.R. Memory consolidation and the medial temporal lobe a simple network model . Proc Natl Acad Sci USA. 91:1994;7041-7045.
3. Ban E., Haour F., Lenstra R. Brain interleukin 1 gene expression induced by peripheral lipopolysaccharide administration. Cytokine. 4:1992;48-54.
4. Barrientos R.M., Higgins E.A., Sprunger D.B., Watkins L.R., Rudy J.W., Maier S.F. Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus. Behav Brain Res. 134:2002;291-298.
5. Gibertini M., Newton C., Friedman H., Klein T.W. Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta. Brain Behav Immun. 9:1995;113-128.
6. Grant S.G., O'Dell T.J., Karl K.A., Stein P.L., Soriano P., Kandel E.R. Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science. 258:1992;1903-1910.
7. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L.I.I.I., Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA. 86:1989;7611-7615.
8. Hall J., Thomas K.L., Everitt B.J. Rapid and selective induction of BDNF expression in the hippocampus during contextual learning. Nat Neurosci. 3:2000;533-535.
9. Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J.D., Wenk G.L. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res. 780:1998;294-303.
10. Korte M., Kang H., Bonhoeffer T., Schuman E. A role for BDNF in the late-phase of hippocampal long-term potentiation. Neuropharmacology. 37:1998;553-559.
11. Kwok R.P., Lundblad J.R., Chrivia J.C., Richards J.P., Bachinger H.P., Brennan R.G., Roberts S.G., Green M.R., Goodman R.H. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature. 370:1994;223-226.
12. Lahiri T., Moore P.E., Baraldo S., Whitehead T.R., McKenna M.D., Panettieri R.A. Jr, Shore S.A. Effect of IL-1beta on CRE-dependent gene expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 283:2002;L1239-L1246.
13. Lapchak P.A., Araujo D.M., Hefti F. Systemic interleukin-1 beta decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation. Neuroscience. 53:1993;297-301.
14. Linthorst A.C., Flachskamm C., Holsboer F., Reul J.M. Local administration of recombinant human interleukin-1 beta in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity, and body temperature. Endocrinology. 135:1994;520-532.
15. Lombardi V.R., Garcia M., Rey L., Cacabelos R. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's disease (AD) individuals. J Neuroimmunol. 97:1999;163-171.
16. Ma T.C., Zhu X.Z. Suppression of lipopolysaccharide-induced impairment of active avoidance and interleukin-6-induced increase of prostaglandin E2 release in rats by indometacin. Arzneimittelforschung. 47:1997;595-597.
17. Ma Y.L., Wang H.L., Wu H.C., Wei C.L., Lee E.H. Brain-derived neurotrophic factor antisense oligonucleotide impairs memory retention and inhibits long-term potentiation in rats. Neuroscience. 82:1998;957-967.
18. Maier S.F., Watkins L.R., Nance D.M. Multiple routes of action of interleukin-1 on the nervous system. Ader R., Felton D.L., Cohen N., Felton D.L. Psychoneuroimmunology. 2001;563-584 Academic Press, New York.
19. Messaoudi E., Ying S.W., Kanhema T., Croll S.D., Bramham C.R. Brain-derived neurotrophic factor triggers transcription-dependent, late phase long-term potentiation in vivo. J Neurosci. 22:2002;7453-7461.
20. Mizuno M., Yamada K., Olariu A., Nawa H., Nabeshima T. Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats. J Neurosci. 20:2000;7116-7121.
21. MohanKumar S.M., MohanKumar P.S., Quadri S.K. Lipopolysaccharide-induced changes in monoamines in specific areas of the brain blockade by interleukin-1 receptor antagonist . Brain Res. 824:1999;232-237.
22. Murray K.D., Gall C.M., Jones E.G., Isackson P.J. Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin- dependent protein kinase messenger RNA expression in Alzheimer's disease. Neuroscience. 60:1994;37-48.
23. Nee L.E., Lippa C.F. Alzheimer's disease in 22 twin pairs-13-year follow-up hormonal, infectious and traumatic factors . Dement Geriatr Cogn Disord. 10:1999;148-151.
24. Nguyen K.T., Deak T., Owens S.M., Kohno T., Fleshner M., Watkins L.R., Maier S.F. Exposure to acute stress induces brain interleukin-1beta protein in the rat. J Neurosci. 18:1998;2239-2246.
25. Nguyen P.V., Abel T., Kandel E.R. Requirement of a critical period of transcription for induction of a late phase of LTP. Science. 265:1994;1104-1107.
26. Oitzl M.S., van Oers H., Schobitz B., de Kloet E.R. Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning. Brain Res. 613:1993;160-163.
27. Parry G.C., Mackman N. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J Immunol. 159:1997;5450-5456.
28. Perry V.H., Newman T.A., Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nat Rev Neurosci. 4:2003;103-112.
29. Phillips H.S., Hains J.M., Armanini M., Laramee G.R., Johnson S.A., Winslow J.W. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron. 7:1991;695-702.
30. Pugh C.R., Johnson J.D., Martin D., Rudy J.W., Maier S.F., Watkins L.R. Human immunodeficiency virus-1 coat protein gp120 impairs contextual fear conditioning a potential role in AIDS related learning and memory impairments . Brain Res. 861:2000;8-15.
31. Pugh C.R., Kumagawa K., Fleshner M., Watkins L.R., Maier S.F., Rudy J.W. Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning. Brain Behav Immun. 12:1998;212-229.
32. Pugh C.R., Nguyen K.T., Gonyea J.L., Fleshner M., Wakins L.R., Maier S.F., Rudy J.W. Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation. Behav Brain Res. 106:1999;109-118.
33. Rasmusson A.M., Shi L., Duman R. Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock. Neuropsychopharmacology. 27:2002;133-142.
34. Rubin S.A., Sylves P., Vogel M., Pletnikov M., Moran T.H., Schwartz G.J., Carbone K.M. Borna disease virus-induced hippocampal dentate gyrus damage is associated with spatial learning and memory deficits. Brain Res Bull. 48:1999;23-30.
35. Rudy J.W. Postconditioning isolation disrupts contextual conditioning an experimental analysis . Behav Neurosci. 110:1996;238-246.
36. Rudy J.W., Kuwagama K., Pugh C.R. Isolation reduces contextual but not auditory-cue fear conditioning a role for endogenous opioids . Behav Neurosci. 113:1999;316-323.
37. Schafe G.E., Nadel N.V., Sullivan G.M., Harris A., LeDoux J.E. Memory consolidation for contextual and auditory fear conditioning is dependent on protein synthesis, PKA, and MAP kinase. Learn Mem. 6:1999;97-110.
38. Shieh P.B., Hu S.C., Bobb K., Timmusk T., Ghosh A. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron. 20:1998;727-740.
39. Smith M.A., Makino S., Kvetnansky R., Post R.M. Effects of stress on neurotrophic factor expression in the rat brain. Ann NY Acad Sci. 771:1995;234-239.
40. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron. 20:1998;709-726.
41. Tyler W.J., Alonso M., Bramham C.R., Pozzo-Miller L.D. From acquisition to consolidation on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning . Learn Mem. 9:2002;224-237.
42. Ueyama T., Kawai Y., Nemoto K., Sekimoto M., Tone S., Senba E. Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci Res. 28:1997;103-110.
43. Vaidya V.A., Terwilliger R.M., Duman R.S. Role of 5-HT2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci Lett. 262:1999;1-4.